| Issue Type | Login |
|---|---|
| Country | United States |
| Industry | Login |
| Region | Login |
| Maturity Date | 2031-11-01 |
| Par Value | 100000 |
| Callable | Login |
| Next Call Date | Login |
| Call Type | Login |
| Call Price (%) | Login |
| Series | Login |
| Class | Login |
| Maturity Structure | Login |
| Amount Outstanding (mil) | 600.00 |
| Coupon | 0.625 |
|---|---|
| Coupon Type | Login |
| Coupon Frequency | Login |
| First Coupon Date | Login |
| Last Coupon Date | Login |
| Sinking Fund | Login |
|---|---|
| Security | Login |
| Subordination | Login |
| Debt Type | Login |
| Issue Date | Login |
|---|---|
| Dated Date | Login |
| Issue Size (mil) | 600.000 |
| Min. Piece | Login |
| Min. Increment | Login |
This Lilly(Eli) & Co corporate note has a 0.63% fixed rate coupon paid on a Login basis. It was issued on MAR 12, 2000 with an issue size of 600.00 million EUR and matures on November 01, 2031 with a last coupon date of FEB 28, 2020. |
Lilly (Eli) & Co, founded in 1876 and headquartered in Indianapolis, Indiana, is a global leader in pharmaceutical innovation dedicated to creating life-changing medicines. The company specializes in developing innovative treatments across several therapeutic areas, including oncology, diabetes, and immunology, with a commitment to improving patient outcomes.